Imperial spin-out NK:IO, a leader in Natural Killer (NK) cell biology, has announced a collaborative project with the Cell and Gene Therapy Catapult for the advancement of potent cell therapies targeting solid tumours. Click to read more.
NK:IO, a leader in natural killer (NK) cell biology applied to the development of potent, off-the-shelf cell therapies targeting solid tumors, has raised £1.2m.
NK:IO Raises £1 2M, Bringing Total Seed Funding to £5 1M, to Advance Pioneering NK Cell Therapy finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.